Geriatric Depression Scale (GDS-15) for Older Adults with Unintentional Weight Loss
For an older adult experiencing unintentional weight loss, use the 15-item Geriatric Depression Scale (GDS-15), which takes 5-7 minutes to complete and has a cutoff score of ≥5 indicating depression requiring follow-up. 1, 2
Why the GDS-15 is Optimal for This Population
The GDS-15 is specifically designed for older adults and offers critical advantages in the context of unintentional weight loss:
Excludes somatic symptoms: Unlike other depression scales, the GDS focuses on positive and negative affective symptoms while deliberately avoiding physical symptom items 1. This is crucial because weight loss, fatigue, and sleep disturbance could reflect either depression or underlying medical illness—the GDS-15 prevents confounding these domains.
Validated specifically for geriatric populations: The scale was developed to capture depressive symptoms more common among the elderly and has robust validation in this age group 1, 2
Quick and practical: Takes only 5-7 minutes to complete, can be self-administered or provider-administered, and requires minimal training 3
Strong evidence base: The 2018 ASCO Geriatric Oncology guideline specifically recommends the GDS-15 for depression screening in older adults, noting its association with unexpected hospitalizations, treatment tolerance, mortality, and functional decline 2
Scoring and Interpretation
- Score ≥5: Suggests depression and necessitates follow-up 1, 2
- Score 5-8: Potential mild depression
- Score 9-11: Moderate depression
- Score 12-15: Severe depression 4
Alternative Validated Options
If the GDS-15 is unavailable or impractical:
Patient Health Questionnaire-9 (PHQ-9): Also recommended by ASCO guidelines for depression screening in older adults 2. The PHQ-9 has 94% specificity in adults and takes approximately 3-5 minutes 5, 6. However, it includes somatic symptoms (sleep, appetite, energy) that may overlap with medical causes of weight loss, potentially reducing specificity in this clinical context.
PHQ-2 as initial screen: Can be used as a rapid first-line screen (97% sensitivity, 67% specificity) 5. If positive, follow with either GDS-15 or PHQ-9 7, 8, 5.
Critical Clinical Caveats
Rule out medical causes first: Before attributing symptoms to depression, evaluate for:
- Malignancy
- Hyperthyroidism
- Gastrointestinal disorders
- Medication side effects
- Uncontrolled diabetes
- Dementia with behavioral changes 1, 2
Cognitive impairment considerations: If cognitive impairment is suspected, the GDS-15 becomes less reliable in more advanced dementia 4. In such cases, consider the Cornell Scale for Depression in Dementia (CSDD), which can be administered even when patients cannot reliably answer questions 4.
Delirium must be excluded: Use the Confusion Assessment Method if acute confusion is present, as delirium can mimic depression 8
Implementation in Practice
- Administer GDS-15 at the initial visit when unintentional weight loss is identified
- Score ≥5 triggers comprehensive depression evaluation using DSM-5 criteria
- Simultaneously investigate medical causes of weight loss
- If depression confirmed, initiate evidence-based treatment (psychotherapy and/or antidepressants)
- Ensure systems are in place for accurate diagnosis, effective treatment, and appropriate follow-up before screening 7, 6
The GDS-15 remains the gold standard for depression screening in older adults specifically because it avoids the diagnostic confusion created by somatic symptoms that could have multiple etiologies in this population.